Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024Nicolas de Prost, D Fofana, Sébastien Préau et al.|Annals of Intensive Care|2024Cited by 13
Complement augments antibody neutralization of SARS-CoV-2 variantsMartin Groznica, Stephane Marot, Pierre Rosenbaum et al.|Science Translational Medicine|2026Cited by 0